[Adrenal gland scintigraphy].
The exact localization of adrenal lesions can be achieved by noninvasive procedures. Whereas radiological methods reflect morphological changes, scintigraphy of adrenal cortex and medulla depends on function. - Radiolabeled 6 beta-methyl-19-norcholesterol is used for adrenocortical scintigraphy in primary aldosteronism, Cushing's syndrome and hyperandrogenism. By dexamethasone suppression a correct classification of adrenocortical lesions by scintigraphy can be observed in about 89% with a specificity of 86%. 123-I- and 131-I-metaiodobenzylguanidine is used for specific scintigraphy of the adrenal medulla. This method is a safe and reliable method for localization of adrenal and extraadrenal pheochromocytomas.
D015071:19-Iodocholesterol / Q000031:analogs & derivatives; D019797:3-Iodobenzylguanidine; D000307:Adrenal Gland Diseases / Q000000981:diagnostic imaging*; D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging; D002784:Cholesterol / Q000031:analogs & derivatives; D003480:Cushing Syndrome / Q000000981:diagnostic imaging; D003907:Dexamethasone; D006801:Humans; D006929:Hyperaldosteronism / Q000000981:diagnostic imaging; D007462:Iodobenzenes; D010673:Pheochromocytoma / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D012643:Selenium; D004113:Succimer; D013667:Technetium; D019783:Technetium Tc 99m Dimercaptosuccinic Acid
D007462:Iodobenzenes; D015071:19-Iodocholesterol; D019797:3-Iodobenzylguanidine; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; C016726:selenonorcholesterol; C035501:6-iodomethylcholesterol; D013667:Technetium; D003907:Dexamethasone; D002784:Cholesterol; D004113:Succimer; D012643:Selenium
Nebennierenszintigraphie.